Quantum Matrix Expands Alzheimer's Testing Sites, Full-Scale Push for New Growth Engine
Predicted impact: Medium
More Alzheimer's test sites for a small company (market value ~₩44B); no contract size disclosed.
QuantaMatrix퀀타매트릭스
317690 · KOSDAQ · ₩317690 · 퀀타매트릭스
₩2,060▼ ₩85 (3.96%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y −54.17%
- Market cap
- ₩41B
- Enterprise value
- ₩19B
- P/E
- —
- P/B
- 1.3×
- Dividend yield
- 0.0%
- ROE
- −55.6%
- Net margin
- −567.5%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−63.6% from the high
₩1,927Today: ₩2,060 – ₩2,230₩5,660
Returns
- 1W−8.8%
- 1M−5.9%
- 3M−3.1%
- 6M−47.2%
- YTD−57.0%
- 1Y−54.2%
- Volume today
- 38,319
- 1.0× the 20-day average
- Traded today
- ₩80M
- Listed shares
- 20,135,029
- EPS (12 months)
- −₩886
- Earnings yield −43.0%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumWeak-5.3% over the last month; the price is below its 20-day average.
- News impactSome1 news items and filings in two weeks; 0 rated high impact, 1 medium.
Signals describe activity, not recommendations. Not financial advice.
QuantaMatrix stock overview
QuantaMatrix (퀀타매트릭스, KRX: 317690) is listed on KOSDAQ, in the Medical & precision devices sector. The company develops, manufactures and sells in vitro diagnostic (IVD) medical devices used to detect and monitor diseases from human samples such as blood, urine and body fluids. Its shares closed at ₩2,060 on Oct 27, 2026, down 3.96% on the day, giving it a market value of ₩41B.
Key facts
- Market cap
- ₩41B
- Sector
- Medical & precision devices
- Latest price change
- −3.96%
- As of
- Oct 27, 2026
- Main business
- The company develops, manufactures and sells in vitro diagnostic (IVD) medical devices used to detect and monitor diseases from human samples such as blood, urine and body fluids.
Quick answers about QuantaMatrix
- What does QuantaMatrix do?
- The company develops, manufactures and sells in vitro diagnostic (IVD) medical devices used to detect and monitor diseases from human samples such as blood, urine and body fluids. Its main products are the dRAST rapid antimicrobial susceptibility test for sepsis and the QMIA-based Alz plus assay kit that helps indicate brain beta-amyloid accumulation. It sells mainly to tertiary hospitals and testing service providers in Korea and overseas, with exports to markets including Europe, Southeast Asia and Latin America.
- What is the market cap of QuantaMatrix?
- The market capitalisation of QuantaMatrix was ₩41B at the close on Oct 27, 2026.
- Who are the largest shareholders of QuantaMatrix?
- According to the latest official filings, the largest reported holders are Pentastone No. 3 New Technology Investment Partnership (29.81%, as of Dec 30, 2025); Ezra Charitable Trust (16.38%, as of Jan 26, 2026); Kwon Seong-hoon (12.38%, as of Apr 1, 2026).
- When is the next earnings report from QuantaMatrix?
- Korean companies rarely announce results dates in advance. Based on when QuantaMatrix filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own QuantaMatrix?
- Yes. The National Pension Service held 0.75% of QuantaMatrix shares as of Dec 31, 2021.
Company profile
The company develops, manufactures and sells in vitro diagnostic (IVD) medical devices used to detect and monitor diseases from human samples such as blood, urine and body fluids. Its main products are the dRAST rapid antimicrobial susceptibility test for sepsis and the QMIA-based Alz plus assay kit that helps indicate brain beta-amyloid accumulation. It sells mainly to tertiary hospitals and testing service providers in Korea and overseas, with exports to markets including Europe, Southeast Asia and Latin America.
Written by AI from the company's latest annual report.
- Korean name
- 퀀타매트릭스
- CEO
- 권성훈, 홍영석 (공동대표이사)
- Founded
- Nov 2010
- Listed
- Dec 2020
- Listed shares
- 20,135,029
- Fiscal year ends
- Month 12
- Website
- www.quantamatrix.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent news
Recent filings
See all- Notice of Company Name ChangeSep 15, 2026
- Results of Extraordinary Shareholders' MeetingSep 15, 2026
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before MaturitySep 8, 2026
- Notice of shareholders' meetingAug 31, 2026
- Amended: Shareholders' meeting calledAug 28, 2026
Titles in Korean until English translations are added.
Also known as: QuantaMatrix / 퀀타매트릭스 / 317690 / KRX:317690
Source: KRX statistical information